EDAP TMS Future Growth
Future criteria checks 2/6
EDAP TMS is forecast to grow earnings and revenue by 50.7% and 20.9% per annum respectively while EPS is expected to grow by 51.3% per annum.
Key information
50.7%
Earnings growth rate
51.3%
EPS growth rate
Medical Equipment earnings growth | 16.4% |
Revenue growth rate | 20.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 08 Nov 2024 |
Recent future growth updates
Recent updates
Potential Upside For EDAP TMS S.A. (NASDAQ:EDAP) Not Without Risk
Dec 25Is EDAP TMS (NASDAQ:EDAP) Using Debt In A Risky Way?
Oct 24Slammed 35% EDAP TMS S.A. (NASDAQ:EDAP) Screens Well Here But There Might Be A Catch
Sep 07Fewer Investors Than Expected Jumping On EDAP TMS S.A. (NASDAQ:EDAP)
Jul 24There's Reason For Concern Over EDAP TMS S.A.'s (NASDAQ:EDAP) Massive 28% Price Jump
Mar 22Does EDAP TMS (NASDAQ:EDAP) Have A Healthy Balance Sheet?
Mar 03It's A Story Of Risk Vs Reward With EDAP TMS S.A. (NASDAQ:EDAP)
Jan 19Investors Still Waiting For A Pull Back In EDAP TMS S.A. (NASDAQ:EDAP)
Aug 11Is There An Opportunity With EDAP TMS S.A.'s (NASDAQ:EDAP) 20% Undervaluation?
Dec 19EDAP TMS' (NASDAQ:EDAP) Solid Profits Have Weak Fundamentals
Nov 23EDAP TMS stock falls 7% aftermarket on proposed ADS offering
Sep 22EDAP TMS S.A. GAAP EPS of $0.06 beats by $0.09, revenue of $14.97M beats by $1.35M
Aug 24EDAP's Focal One Revenue Is Set To Accelerate
Aug 08Is EDAP TMS (NASDAQ:EDAP) Weighed On By Its Debt Load?
Jul 19Acceleration At EDAP
Jan 11EDAP TMS (NASDAQ:EDAP) Could Easily Take On More Debt
Jan 06The Consensus EPS Estimates For EDAP TMS S.A. (NASDAQ:EDAP) Just Fell A Lot
Nov 25EDAP's HIFU Progress Is Obscured By The Pandemic, But It's Real
Sep 07EDAP's subsidiary names medTech industry veteran Ryan Rhodes as CEO
Jun 15EDAP TMS S.A. (NASDAQ:EDAP) Just Reported Full-Year Earnings And Analysts Are Lifting Their Estimates
Apr 02Analysts Are Betting On EDAP TMS S.A. (NASDAQ:EDAP) With A Big Upgrade This Week
Jan 24Treatment with EDAP's HIFU ultrasound benefits in prostate cancer patients, study shows
Jan 14New reimbursement rules for HIFU technology to favor EDAP TMS
Dec 09Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 124 | -1 | N/A | N/A | 1 |
12/31/2026 | 84 | -14 | N/A | N/A | 3 |
12/31/2025 | 74 | -17 | N/A | N/A | 3 |
12/31/2024 | 64 | -21 | N/A | N/A | 3 |
9/30/2024 | 63 | -22 | -23 | -19 | N/A |
6/30/2024 | 62 | -20 | -19 | -16 | N/A |
3/31/2024 | 61 | -18 | -20 | -16 | N/A |
12/31/2023 | 60 | -21 | -19 | -15 | N/A |
9/30/2023 | 57 | -21 | -21 | -17 | N/A |
6/30/2023 | 57 | -17 | -17 | -13 | N/A |
3/31/2023 | 57 | -11 | -10 | -7 | N/A |
12/31/2022 | 55 | -3 | -5 | -3 | N/A |
9/30/2022 | 53 | 4 | 4 | 6 | N/A |
6/30/2022 | 51 | 3 | 3 | 5 | N/A |
3/31/2022 | 47 | 0 | 2 | 4 | N/A |
12/31/2021 | 44 | 1 | 3 | 4 | N/A |
9/30/2021 | 45 | 0 | 4 | 6 | N/A |
6/30/2021 | 45 | 0 | N/A | N/A | N/A |
3/31/2021 | 44 | 0 | N/A | N/A | N/A |
12/31/2020 | 42 | -2 | 0 | 2 | N/A |
9/30/2020 | 38 | -3 | N/A | N/A | N/A |
6/30/2020 | 39 | -2 | N/A | N/A | N/A |
3/31/2020 | 42 | 0 | N/A | N/A | N/A |
12/31/2019 | 45 | 2 | 2 | 4 | N/A |
9/30/2019 | 46 | 4 | N/A | N/A | N/A |
6/30/2019 | 44 | 2 | N/A | N/A | N/A |
3/31/2019 | 40 | 0 | N/A | N/A | N/A |
12/31/2018 | 39 | 0 | -2 | 0 | N/A |
9/30/2018 | 36 | -1 | N/A | N/A | N/A |
6/30/2018 | 35 | -1 | N/A | 0 | N/A |
3/31/2018 | 36 | -2 | N/A | N/A | N/A |
12/31/2017 | 36 | -1 | N/A | -3 | N/A |
9/30/2017 | 36 | -2 | N/A | N/A | N/A |
6/30/2017 | 37 | 0 | N/A | -4 | N/A |
3/31/2017 | 36 | 4 | N/A | N/A | N/A |
12/31/2016 | 36 | 4 | N/A | 1 | N/A |
9/30/2016 | 37 | 10 | N/A | N/A | N/A |
6/30/2016 | 35 | 4 | N/A | 4 | N/A |
3/31/2016 | 35 | 2 | N/A | N/A | N/A |
12/31/2015 | 32 | -2 | N/A | 1 | N/A |
9/30/2015 | 27 | -9 | N/A | N/A | N/A |
6/30/2015 | 27 | 2 | N/A | -1 | N/A |
3/31/2015 | 25 | -4 | N/A | N/A | N/A |
12/31/2014 | 26 | -1 | N/A | -1 | N/A |
9/30/2014 | 28 | 2 | N/A | N/A | N/A |
6/30/2014 | 27 | -5 | N/A | -1 | N/A |
3/31/2014 | 26 | 0 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EDAP is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: EDAP is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: EDAP is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: EDAP's revenue (20.9% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: EDAP's revenue (20.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EDAP's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/02 03:07 |
End of Day Share Price | 2025/01/02 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
EDAP TMS S.A. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Andrew D'Silva | B. Riley Securities, Inc. |
null null | CG Capital |
Swayampakula Ramakanth | H.C. Wainwright & Co. |